Yersinia Infection 02.10.2012

Embed Size (px)

Citation preview

  • 8/2/2019 Yersinia Infection 02.10.2012

    1/18

    MORNING REPORT

    Liset Olarte MD, PGY2

    February 10, 2012

  • 8/2/2019 Yersinia Infection 02.10.2012

    2/18

    HISTORY

    HPI:

    12y male with abdominal pain off and on "his entire life on his rightside.

    Worsening abdominal pain, backache 2-3 weeks ago.

    Low grade fever , poor appetite for 5 days.

    Diagnosed with asthma and possible pneumonia. Steroids,Azithromycin, and Albuterol.

    3 and 2 days PTA, ER visit: fluids, morphine.

    Has loose stool/constipation, nausea, emesis x1, has lost weight.No blood in stool

  • 8/2/2019 Yersinia Infection 02.10.2012

    3/18

    HISTORY

    PMH

    :- Chronic abdominal pain

    - Encephalitis/meningitis due to West Nile at 4 yo

    MEDS: none

    ALLERGIES: Bactrim

    IMMs: UTD, no flu shot

    FAMILYHX: Mom: rhabdomyolysis, migraines, chronic abdominal pain,

    glaucoma. Sibling chronic abdominal pain. Father's history unknown.

    SOCIAL HX: Lives in WY with mom, 2 younger siblings and mom's boyfriend.Family lives on a farm.

  • 8/2/2019 Yersinia Infection 02.10.2012

    4/18

    PHYSICAL EXAM

    T 37.8, P 98, RR 28, BP 99/61

    Weight 34.5 (7%ile)

    GENERAL: Well appearing, mild distress .

    EYES: EOMI, PERRL, conjunctivae clear, sclerae nonicteric,

    HENT: NC/AT, MMM, NP clear, OP w/o exudates.

    LYMPH: Neck supple, small ~1cm lymph node palpated in the L anterior cervical

    chain.

    LUNGS: CTAB, no increased WOB, good aeration, no adventitious sounds.

    CV: RRR, no M/R/G, nl perfusion and pulses.

    ABD: Soft, tender throughout but significantly worse on RLQ, hypoactive BS , no

    HSM, no mass.GU: Small

  • 8/2/2019 Yersinia Infection 02.10.2012

    5/18

    DIFFERENTIALDIAGNOSIS

    GI: Ulcerative Colitis, Crohn Disease, Appendicitis, Constipation, Mesenteric adenitis,Bowel obstruction, Abdominal migraine, Cholecystitis, Functional abdominal pain,hepatitsi, pancreatitis, meckels diverticulum, gastritis, perforated ulcer, foreign bodyingestion

    ID: Amebiasis, Intraabdominal abscess, Gastroenteritis, Cholangitis, CampylobacterInfections, Clostridium Difficile Colitis, yersinia, shigellosis, salmonellosis

    CV: Myocarditis, pericarditis.

    Resp: Pneumonia

    Endo/metab: diabetic ketoacidosis, acute porphyria

    GU/renal: Urinary tract infection, Urolithiasis,HUS

    Heme/onc: Sickle cell vasooclusive crisis, lymphoma

    Tox: Lead poisoning

  • 8/2/2019 Yersinia Infection 02.10.2012

    6/18

    OSH LABS

    Na 137, K 4, Cl 100, HCO3 27, BUN 11, Cr 0.7, Glu 107, Ca 8.9, Mag 1.9

    CRP 18.8, ESR 34

    Lipase 80

    AST 17, ALT 30, Tbili 0.3, Prot 6.3, Alk phos 270, Alb 3.8

    WBC 12.6 (L 17, M 12, N 77), Hct 38, Plat 192.

    Overread of OSH CT abd:

    1. Terminal ileum and cecal wall thickeningsuggesting IBD, less likely

    infectious enterocolitis.

    2. Right lower quadrant mesenteric adenopathy.

    3. No free air. No intra-abdominal abscess. Remainder of the bowelappears normal.

    CXR: Normal.

  • 8/2/2019 Yersinia Infection 02.10.2012

    7/18

    PCMC

    CRP 18, ESR 50

    HFP, uric acid, LDH normal

    Blood and stool culture sent

    DOH #2 Endoscopy showed:

    Normal esophagus and duodenum,

    Gastritis with patchy erythema.

    Purulent exudate at ileum and thickened, beefy IC valve.

    Patchy ulcerations in proximal colon through mid-transverse colon.

    No anal lesions.

    He was started on IV Solumedrol Prednisone.

    PPD placed in case he needed Remicade. Morphine oxycodone and levsin for pain.

    DOH #3 Blood culture : Gram negative bacilli. Started on IV Zosyn and POFlagyl.

  • 8/2/2019 Yersinia Infection 02.10.2012

    8/18

    PCMC

    DOH #5

    Blood culture: Yersinia enterocolitica. S: ampicillin/sulbactam, cefepime, cefoxitin, ceftazidime, ceftriaxone, ciprofloxacin,

    gentamicin, imipenem, levofloxacin, meropenem, tobramycin

    I: ampicillin

    R: cefazolin, trimeth/sulfa

    Discontinued prednisone

    Antibiotics switched to Ceftriaxone and Gentamicin

    Transitioned to PO Ciprofloxacin

    Pathology report: Acute enterocolitis, with minimal chronic change noted .

    Day after discharge Stool culture positive for Yersinia enterocolitica.

  • 8/2/2019 Yersinia Infection 02.10.2012

    9/18

    YERSINIA INFECTION

  • 8/2/2019 Yersinia Infection 02.10.2012

    10/18

    WHY IS YERSINIA INFECTION

    IMPORTANT?

    The incidence ofYersinia infections is highest in youngchildren.

    77.6% of infections occurred in children aged < 12 months.

    Young children are susceptible due to their immatureimmune systems.

    17,000 cases occur annually in the United States

    530 cases will be severe enough to require hospitalization 29 deaths are possible each year.

  • 8/2/2019 Yersinia Infection 02.10.2012

    11/18

    YERSINIA ENTEROCOLITICA

    Gram-negative bacillus

    Healthy pigs are frequently colonized with

    strains that cause human illness Can be found in dogs, cats, pigs, cows, sheep,

    goats, rodents, foxes, and birds.

    More common duringwinter months(psychrophilic)

    More common in developed countries.

  • 8/2/2019 Yersinia Infection 02.10.2012

    12/18

    TRANSMISSION

    Contaminated food, raw or undercooked

    pork products.

    Contaminated unpasteurized milk or

    untreated water

    Contact with infected animals.

    Transfusion of stored blood from

    asymptomatic donors.

    Cross-contamination: hands of theperson handling the raw food bottle,

    pacifier, toys of the infant.

  • 8/2/2019 Yersinia Infection 02.10.2012

    13/18

    CLINICAL PRESENTATION

    Incubation period is typically 46 days

    Most frequently associated:

    acute diarrhea (1-3 weeks)

    terminal ileitis

    mesenteric lymphadenitis

    Pseudoappendicitis

    Infected individuals may shed Y enterocolitica instools for 90 days after the symptom resolution.

    The most prominent clinical manifestations in youngchildren are fever and diarrhea (bloody)

  • 8/2/2019 Yersinia Infection 02.10.2012

    14/18

    COMPLICATIONS

    GASTROINTESTINAL EXTRAINTESTINAL

    Diffuse ulcerating ileitis and

    colitis

    Intestinal perforation

    Peritonitis

    Intussusception

    Paralytic ileus

    Toxic megacolon

    Necrotic small bowel

    Cholangitis

    Mesenteric vein thrombosis

    Bacteremia

    Hepatic, splenic, renal, lung

    abscess

    Pharyngeal abscess

    Endocarditis

    Meningitis

    Osteomyelitis

    Septic arthritis

    Suppurative lymphadenitis

  • 8/2/2019 Yersinia Infection 02.10.2012

    15/18

    BACTEREMIA

    Most often in children < 12months

    Older children with predisposing conditions :immunosuppresive state or iron overload storage(ferrophilic )(thalassemias, sickle cell disease,hemochromatoses)

    Death is uncommon, but Y enterocoliticabacteremia carries a case fatality rate of 35%.

  • 8/2/2019 Yersinia Infection 02.10.2012

    16/18

    POST-INFECTIOUS SEQUELAE

    Reactive arthritis, large

    weight-bearing joints

    (knees, ankles, wrists).1 month after the

    initial episode of

    diarrhea

    resolves in 1 to 6

    months.HLA-B27 is typically

    present

    Proliferative

    glomerulonephritis

    Erythema nodosum,resolves within a month.

  • 8/2/2019 Yersinia Infection 02.10.2012

    17/18

    DIAGNOSIS

    CIN agar, selective medium withincreased yield for Y

    enterocolitica

    Recovery from sterile samples(blood, CSF, lymph node tissue)is usually faster than stoolsamples.

    Serologic assays are of limitedclinical utility due to cross-

    reactivity (Brucella, Salmonella,Rickettsia, E.coli)

  • 8/2/2019 Yersinia Infection 02.10.2012

    18/18

    TREATMENT

    Uncomplicated cases of diarrhea resolve on their own

    Antibiotic treatment may reduce the duration of fecal shedding.

    In severe or complicated infections: aminoglycosides, doxycycline, TMP-

    SMX, or fluoroquinolones

    Bacteremia treat for 3 weeks.

    Ceftriaxone + gentamicin

    Ciprofloxacin

    Antimicrobial therapy has no effect on post-infectious sequelae

    Rapid microbiologic clearance of the organism